{"id":535844,"date":"2021-09-08T16:04:13","date_gmt":"2021-09-08T20:04:13","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/"},"modified":"2021-09-08T16:04:13","modified_gmt":"2021-09-08T20:04:13","slug":"cullinan-oncology-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Cullinan Oncology to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">CAMBRIDGE, Mass., Sept.  08, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P8Om8F1JnLBFRH2susK-d2u8jqFDxbpcx5t3IPXFdjjDe6cL7C8yU3X5-qu3btpZcsEkiWFftsPbVWEblJS1j-2S6y5YZQtgeF2WBTWSXQs=\" rel=\"nofollow noopener\" target=\"_blank\">Cullinan Oncology, Inc.<\/a> (Nasdaq: CGEM) (\u201cCullinan\u201d) today announced its participation in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Morgan Stanley 19<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Healthcare Conference <\/strong>taking place Thursday, September 9<sup>th<\/sup> through Wednesday, September 15<sup>th<\/sup><\/p>\n<ul type=\"circle\">\n<li>Cullinan\u2019s CEO, Owen Hughes, will participate in a virtual fireside chat on Monday, September 13<sup>th<\/sup>, at 12:30pm ET, and will provide a corporate update at 4:15pm ET<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>H.C. Wainwright 23<\/strong><br \/>\n          <sup><br \/>\n            <strong>rd<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Investment Conference <\/strong>on Monday, September 13<sup>th<\/sup> through Wednesday, September 15<sup>th<\/sup><\/p>\n<ul type=\"circle\">\n<li>Cullinan\u2019s Chief Development Officer of Biologics, Jennifer Michaelson, will participate in a panel discussion titled \u201cEngineered Cytokines: The Next Big Wave in Immuno-oncology\u201d, which will be broadcast to conference participants on Tuesday, September 14<sup>th<\/sup>, from 1:30 \u2013 3:00pm ET<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>Members of Cullinan\u2019s management will be presenting virtually at each conference, as well as participating in one-on-one investor meetings. Please visit the investor section of Cullinan\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E5_NbmF2LcBjoi20zUfYIFbYlwSGy9mNebhl1foalRHXVOnJGLF8_-Vmb5UGUFSvjq8dSKZiriA5pvUapFNCtUBUcQxAO4NqkPyKajJzk7NBBLyzPAJvcqAWbosauM3o\" rel=\"nofollow noopener\" target=\"_blank\">www.investors.cullinanoncology.com<\/a> for more information.<\/p>\n<p>\n        <strong>About Cullinan Oncology<\/strong>\n      <\/p>\n<p>Cullinan Oncology is a biopharmaceutical company that strives to deliver results for our various stakeholders through disciplined capital allocation, decisive action, prudent risk taking and creative business development. We seek to drive shareholder returns by focusing on the patient. The Company\u2019s strategy is to build a diversified pipeline of targeted and immuno-oncology therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes. Learn more about Cullinan at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FBZoVCQVm7rteYsirm1XqDLvRCLPPqYw92xyNTGo81RT5d7kBtTGGJj7ELqOqxTn-tZkYX0GrSHCsW94pDH_nltsTWA1ZTziL6BsnUPsL5U=\" rel=\"nofollow noopener\" target=\"_blank\">www.cullinanoncology.com<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=L-mBYUSGuWJPoU-8NAMehqR1Z7kwtNOdidJc27cCwBm0sAW68-9-LSGtoJbG62xq5acq9O2ZWZ2Joyhof35T41GJpiPXMRzS9NZenlArvTPBbQ8P2oOx0_IyKRkP0NFY\" rel=\"nofollow noopener\" target=\"_blank\">investors@cullinanoncology.com<\/a><\/p>\n<p>Jeff Trigilio<br \/>+1 617.410.4650<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AsUytJHSZ4YlpvuCTSRxrBkFSfWQsW_mz05uvgCAMxcrM8ZxsadUrmgd9D7yKqOV74dV6dHR1-b68YU-QbLupdQ3kryNKU6wfghRf3JRYHqXfTbP69tz-0-qbIh8afI6\" rel=\"nofollow noopener\" target=\"_blank\">jtrigilio@cullinanoncology.com<\/a><\/p>\n<p>\u00a0<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2M1ZjI4ZTYtOTA0OS00Mjg2LWFhNDMtNmVhNjU1NDdlMDJjLTEyMTc0MjY=\/tiny\/Cullinan-Management-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Cullinan Oncology, Inc. (Nasdaq: CGEM) (\u201cCullinan\u201d) today announced its participation in the following upcoming investor conferences: Morgan Stanley 19 th Annual Global Healthcare Conference taking place Thursday, September 9th through Wednesday, September 15th Cullinan\u2019s CEO, Owen Hughes, will participate in a virtual fireside chat on Monday, September 13th, at 12:30pm ET, and will provide a corporate update at 4:15pm ET H.C. Wainwright 23 rd Annual Global Investment Conference on Monday, September 13th through Wednesday, September 15th Cullinan\u2019s Chief Development Officer of Biologics, Jennifer Michaelson, will participate in a panel discussion titled \u201cEngineered Cytokines: The Next Big Wave in Immuno-oncology\u201d, which will be broadcast to conference participants on Tuesday, September 14th, from 1:30 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cullinan Oncology to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-535844","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cullinan Oncology to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cullinan Oncology to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Cullinan Oncology, Inc. (Nasdaq: CGEM) (\u201cCullinan\u201d) today announced its participation in the following upcoming investor conferences: Morgan Stanley 19 th Annual Global Healthcare Conference taking place Thursday, September 9th through Wednesday, September 15th Cullinan\u2019s CEO, Owen Hughes, will participate in a virtual fireside chat on Monday, September 13th, at 12:30pm ET, and will provide a corporate update at 4:15pm ET H.C. Wainwright 23 rd Annual Global Investment Conference on Monday, September 13th through Wednesday, September 15th Cullinan\u2019s Chief Development Officer of Biologics, Jennifer Michaelson, will participate in a panel discussion titled \u201cEngineered Cytokines: The Next Big Wave in Immuno-oncology\u201d, which will be broadcast to conference participants on Tuesday, September 14th, from 1:30 &hellip; Continue reading &quot;Cullinan Oncology to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T20:04:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cullinan Oncology to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2021-09-08T20:04:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":280,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Cullinan Oncology to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=\",\"datePublished\":\"2021-09-08T20:04:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cullinan Oncology to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cullinan Oncology to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Cullinan Oncology to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) &#8212; Cullinan Oncology, Inc. (Nasdaq: CGEM) (\u201cCullinan\u201d) today announced its participation in the following upcoming investor conferences: Morgan Stanley 19 th Annual Global Healthcare Conference taking place Thursday, September 9th through Wednesday, September 15th Cullinan\u2019s CEO, Owen Hughes, will participate in a virtual fireside chat on Monday, September 13th, at 12:30pm ET, and will provide a corporate update at 4:15pm ET H.C. Wainwright 23 rd Annual Global Investment Conference on Monday, September 13th through Wednesday, September 15th Cullinan\u2019s Chief Development Officer of Biologics, Jennifer Michaelson, will participate in a panel discussion titled \u201cEngineered Cytokines: The Next Big Wave in Immuno-oncology\u201d, which will be broadcast to conference participants on Tuesday, September 14th, from 1:30 &hellip; Continue reading \"Cullinan Oncology to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-08T20:04:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cullinan Oncology to Participate in Upcoming Investor Conferences","datePublished":"2021-09-08T20:04:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/"},"wordCount":280,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/","name":"Cullinan Oncology to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=","datePublished":"2021-09-08T20:04:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMjQwNCM0Mzk1NDAwIzIyMDU4NzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cullinan-oncology-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cullinan Oncology to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535844","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=535844"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/535844\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=535844"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=535844"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=535844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}